Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s ...

The Global Medical Adhesive Tapes Market is projected to grow at a CAGR of 6.5% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals that the market ...

Akebia filed its Investigational New Drug Application with the U.S. Food and Drug Administration (FDA) and recently initiated ...

New analyses from the ongoing open label extension (OLE) studies and findings from electroencephalogram (EEG) assessments in ...

Virginia's attorney general and 20 of his counterparts in other states are weighing in on a lawsuit over Arlington Public ...

Your suitcase hasn't appeared at baggage reclaim, and you're starting to panic, but what should you do? A travel expert ...

Industry experts share insights on how companies are adapting through diversification, regionalization, and resilience-focused supply chain strategies.

Incyte announces the appointment of Richard Hoffman as Executive Vice President and General Counsel effective today, December 1, 2025. In his new role, Mr. Hoffman will serve as a key member of the ...

Discusses Positive Topline Results from Phase III DRAGON Trial of Tinlarebant in Stargardt Disease December 1, 2025 8:00 ...

The Dec-25 V25 RGA futures contract jumped $1.72 or 6.4% over the Nov. 24-28 period to settle at $28.64 on ICE Friday, before breaching the $29 threshold for the first time on Monday.

Galmed is currently working on a new sublingual (SL) formulation of Aramchol which will allow the development of a fixed dose combination of Aramchol with an approved metabolic agent. The successful ...